Compare APT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APT | BDSX |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 53.0M |
| IPO Year | 1995 | 2020 |
| Metric | APT | BDSX |
|---|---|---|
| Price | $4.66 | $7.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.50 |
| AVG Volume (30 Days) | 27.3K | ★ 81.4K |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | $59,096,000.00 | ★ $80,173,000.00 |
| Revenue This Year | N/A | $19.04 |
| Revenue Next Year | N/A | $26.39 |
| P/E Ratio | $13.20 | ★ N/A |
| Revenue Growth | N/A | ★ 22.29 |
| 52 Week Low | $4.06 | $3.44 |
| 52 Week High | $6.20 | $32.20 |
| Indicator | APT | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 54.68 | 55.73 |
| Support Level | $4.46 | $7.68 |
| Resistance Level | $4.70 | $8.17 |
| Average True Range (ATR) | 0.18 | 0.63 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 77.80 | 70.74 |
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.